98%
921
2 minutes
20
Background: Ablation for atrial fibrillation targets an arrhythmogenic substrate in the left atrium (LA) myocardium with therapeutic energy, resulting in a scar tissue. Although a global LA function typically improves after ablation, the injured tissue is stiffer and non-contractile. The local functional impact of ablation has not been thoroughly investigated.
Methods: This study retrospectively analyzed the LA mechanics of 15 subjects who received a four-dimensional computed tomography (4DCT) scan pre- and post-ablation for atrial fibrillation. LA volumes were automatically segmented at every frame by a trained neural network and converted into surface meshes. A local endocardial strain was computed at a resolution of 2 mm from the deforming meshes. The LA endocardial surface was automatically divided into five walls and further into 24 sub-segments using the left atrial positioning system. Intraoperative notes gathered during the ablation procedure informed which regions received ablative treatment.
Results: In an average of 18 months after ablation, the strain is decreased by 16.3% in the septal wall and by 18.3% in the posterior wall. In subjects who were imaged in sinus rhythm both before and after the procedure, the effect of ablation reduced the regional strain by 15.3% (p = 0.012). Post-ablation strain maps demonstrated spatial patterns of reduced strain which matched the ablation pattern.
Conclusion: This study demonstrates the capability of 4DCT to capture high-resolution changes in the left atrial strain in response to tissue damage and explores the quantification of a regionally reduced LA function from the scar tissue.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10840-025-02087-8 | DOI Listing |
Eur Urol Focus
September 2025
Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Background And Objective: While whole-gland therapies for localized prostate cancer (PCa) offer excellent oncological outcomes, these can impact patients' quality of life (QoL) through serious side effects. Focal therapy using high-intensity focused ultrasound (HIFU) has emerged as a less invasive alternative to preserve QoL. However, data on the psychological impact of HIFU remain rare.
View Article and Find Full Text PDFInterdiscip Cardiovasc Thorac Surg
September 2025
Department of Electrophysiology, Abbott Inc, Chicago, IL.
We report the first use of the EnSite X system for intraoperative electrophysiological mapping during a robotic hybrid ablation (ROK-AF procedure) for long-standing persistent atrial fibrillation. Epicardial ablation targets were identified, and post-ablation electrical silencing was validated. Unlike conventional systems, its orientation-independent omnipolar technology provides directional activation vectors, high-resolution electrograms, and peak frequency analysis, thereby enhancing substrate characterisation.
View Article and Find Full Text PDFDan Med J
August 2025
Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hospital.
Introduction: Long-term cardiac monitoring has become more accessible with the advent of consumer-oriented wearable devices. Smartwatches (SWs) hold promise for extended rhythm monitoring owing to their availability and direct electronic health record (EHR) integration. We studied the clinical consequences of SW implementation in patients with palpitations.
View Article and Find Full Text PDFFront Immunol
September 2025
Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
NSG-SGM3 humanized mouse models are well-suited for studying human immune physiology but are technically challenging and expensive. We previously characterized a simplified NSG-SGM3 mouse, engrafted with human donor CD34 hematopoietic stem cells without receiving prior bone marrow ablation or human secondary lymphoid tissue implantation, that still retains human mast cell- and basophil-dependent passive anaphylaxis responses. Its capacities for human antibody production and human B cell maturation, however, remain unknown.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
September 2025
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: To evaluate predictors of outcomes in colorectal liver metastases (CLM) patients undergoing 90Y radioembolization (TARE), focusing on the impact of tumor absorbed dose.
Materials And Methods: Patients' characteristics and dosimetry assessments were analyzed in 231 patients undergoing 329 TARE sessions from 09/2009 to 07/2023. Response was assessed using RECIST1.